Resveratrol targets PD-L1 glycosylation and dimerization to enhance antitumor T-cell immunity
Sara Verdura, Elisabet Cuyàs, Èric Cortada, Joan Brunet, Eugeni López‐Bonet, Begoña Martı́n-Castillo, Joaquim Bosch‐Barrera, José Antonio Encinar, Javier A. Menéndez
Abstract
-linked glycan decoration of PD-L1, thereby promoting the endoplasmic reticulum retention of a mannose-rich, abnormally glycosylated form of PD-L1. RSV was also predicted to interact with the inner surface of PD-L1 involved in the interaction with PD-1, almost perfectly occupying the target space of the small compound BMS-202 that binds to and induces dimerization of PD-L1. The ability of RSV to directly target PD-L1 interferes with its stability and trafficking, ultimately impeding its targeting to the cancer cell plasma membrane. Impedance-based real-time cell analysis (xCELLigence) showed that cytotoxic T-lymphocyte activity was notably exacerbated when cancer cells were previously exposed to RSV. This unforeseen immunomodulating mechanism of RSV might illuminate new approaches to restore T-cell function by targeting the PD-1/PD-L1 immunologic checkpoint with natural polyphenols.